Trial · NCT00404924
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-Free Survival (PFS) | Vandetanib 300 mg | 1.9 | 95% Confidence Interval 1.84 to 2.23 | month | |
| Progression-Free Survival (PFS) | Placebo | 1.8 | 95% Confidence Interval 1.74 to 1.84 | month | |
| Objective Response Rate (ORR) | Vandetanib 300 mg | 16 | Participants | ||
| Objective Response Rate (ORR) | Placebo | 2 | Participants | ||
| Disease Control Rate (DCR) | Vandetanib 300 mg | 189 | Participants | ||
| Disease Control Rate (DCR) | Placebo | 48 | Participants | ||
| Duration of Response (DoR) | Vandetanib 300 mg | 23.9 | 95% Confidence Interval 16.57 to 27.00 | Weeks | |
| Duration of Response (DoR) | Placebo | 24.3 | 95% Confidence Interval 16.00 to 32.57 | Weeks | |
| Overall Survival (OS) | Vandetanib 300 mg | 8.5 | 95% Confidence Interval 7.81 to 9.76 | Months | |
| Overall Survival (OS) | Placebo | 7.8 | 95% Confidence Interval 6.08 to 9.17 | Months | |
| Time to Deterioration of Disease-related Symptoms (TDS) by Questionnaire - the Lung Cancer Subscale (LCS) a Selection of the FACT-L Focusing on Symptoms of Lung Cancer Plus Pain and Fatigue (LCS-PF) | Vandetanib 300 mg | 6.1 | Inter-Quartile Range 5.14 to 8.14 | weeks | |
| Time to Deterioration of Disease-related Symptoms (TDS) by Questionnaire - the Lung Cancer Subscale (LCS) a Selection of the FACT-L Focusing on Symptoms of Lung Cancer Plus Pain and Fatigue (LCS-PF) | Placebo | 7.1 | Inter-Quartile Range 5.86 to 8.43 | weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00404924/results